-
Mashup Score: 0Sun Shield: Protecting Beyond Ultraviolet Light - 8 hour(s) ago
Susan Taylor, MD, FAAD, discusses the impact of the solar spectrum on skin health, focusing specifically on the impact of visible light and infrared radiation. She discusses the benefits and limitations of traditional sunscreen ingredients and addresses ways to specifically protect from visible light and infrared radiation. Additionally, she discusses the impact of free radical formation on skin health and how adding antioxidants to sunscreen might optimize skin protection. She also shares her perspective based on her clinical experience on how she talks to her patients about sun protection and how she chooses the right sunscreen for patients in her practice.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0Top 5 Articles of the Week: May 4-9 - 8 hour(s) ago
Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
🌟🗓 Explore the top 5 articles from Dermatology Times from the past week, including insights on the latest clinical trials, therapeutic updates, and more. https://t.co/ZX7fz5zazR #Top5 #DermTwitter
-
-
Mashup Score: 0The Weekly Roundup: May 5-9 - 10 hour(s) ago
In case you missed it, this week we had news about roflumilast’s dual-site efficacy in psoriasis patients, melanoma care in the United States, phase 2a safety and efficacy results of AX-158, and more.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
🗓 Review our recap of news from last week, including roflumilast’s dual-site efficacy in psoriasis patients, melanoma care in the United States, phase 2a safety and efficacy results of AX-158, and more. https://t.co/SAl7qSDOkb #TheWeeklyRoundup #DermTwitter
-
-
Mashup Score: 0The Rx Recap: May 4-10 - 12 hour(s) ago
This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
🗓💊 This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more. 🖇 Read more: https://t.co/IcSSbxKfHC #TheRxRecap #DermTwitter
-
-
Mashup Score: 0Dermatology Times Spot Test: May 10, 2025 - 14 hour(s) ago
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
🔬✨ Put your #dermatology expertise to the test with Dermatology Times’ interactive weekly quiz series! This week, we’ll focus on the intersections between dermatologic conditions and psychological well-being for #MentalHealthAwarenessMonth. https://t.co/MFrGUfz7sP #DermTwitter
-
-
Mashup Score: 1Evaluating Dupilumab and Upadacitinib for Head and Neck AD - 16 hour(s) ago
New research from AAD 2025 highlights upadacitinib’s effectiveness over dupilumab for treating atopic dermatitis, especially in challenging facial and neck areas.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📈 Data from the #AAD2025 meeting shows #upadacitinib may outperform #dupilumab for head and neck atopic dermatitis. https://t.co/8hwNDtAJcN #AtopicDermatitis #AD #DermTwitter
-
-
Mashup Score: 0#DermTok: Navigating TikTok’s Acne Advice Misinformation - 18 hour(s) ago
Social media reshapes dermatology, but misinformation about acne treatments on platforms like TikTok raises concerns among clinicians and patients alike.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📰 With #DermTok booming, dermatologists warn of rampant #acne misinformation on #TikTok as studies show most viral content lacks medical accuracy. https://t.co/WzmZfh08xk #DermTwitter
-
-
Mashup Score: 4Missed Diagnoses, Missed Opportunities: Closing the Gap in Skin Cancer for Patients of Color - 1 day(s) ago
Explore the urgent need for improved skin cancer awareness and care for minority populations, addressing disparities in diagnosis and treatment.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📰 A misdiagnosed #melanoma case in a Black patient highlights urgent gaps in skin cancer care, education, and representation, as Nicole A. Negbenebor, MD, FAAD, stresses that we must ensure equity in diagnosis and treatment. https://t.co/9vJmub1Rrc #SkinCancer #DermTwitter
-
-
Mashup Score: 1Switching Gears in Atopic Dermatitis: How Upadacitinib Helps Patients Reach Optimal Targets After Dupilumab Inadequacy - 1 day(s) ago
Data from the Level Up study shows that switching from dupilumab to upadacitinib enables more patients to achieve optimal targets of skin clearance and itch relief.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📈 New data from the Level Up study show switching from #dupilumab to #upadacitinib helps more atopic dermatitis patients hit optimal skin and itch targets fast. https://t.co/utjrLhLWvT #AtopicDermatitis #AD #DermTwitter
-
-
Mashup Score: 1Abrocitinib Shows Age-Linked Safety Differences - 2 day(s) ago
Recent analysis reveals abrocitinib’s long-term safety in atopic dermatitis, highlighting age-related risks and the importance of tailored dosing for older patients.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📚 A new analysis of #abrocitinib shows it’s generally safe for treating atopic dermatitis, with fewer adverse effects in teens but more risks in adults 65+. https://t.co/CjNN2BqwI4 #AD #AtopicDermatitis #DermTwitter
-
🎥Susan Taylor, MD, FAAD highlights how visible light and infrared radiation impact skin health, where traditional sunscreens fall short, and how antioxidants can enhance protection. https://t.co/t7Z70eJqCo https://t.co/UItaxH0TBL